Skip to main content
Erschienen in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2020

Open Access 01.12.2020 | Research

Retinal nerve fiber layer and ganglion cell layer changes using optical coherence tomography in patients with chronic migraine: a case-control study

verfasst von: Dalia M. Labib, Montaser Hegazy, Soheir Mohamed Esmat, Enas Abdel Hamid Ali, Foraysa Talaat

Erschienen in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Ausgabe 1/2020

Abstract

Background

Migraine is a prevalent, chronic, and multifactorial neurovascular disease.

Objectives

Our work aimed to investigate if the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) thickness are affected in patients with chronic migraine to improve the understanding of the etiology and pathophysiology of migraine.

Subjects and methods

A case-control study conducted on 30 patients with chronic migraine and 30 aged and sex-matched healthy controls. Subjects underwent full neurological and ophthalmological history, ophthalmological examination, and measuring RNFL and GCL thickness using the spectral domain-optical coherence tomography (SD-OCT).

Results

RNFL thinning (average, superior, inferior, nasal, and temporal) was significantly more in patients with chronic migraine than healthy control (P = 0.001, 0.022, 0.045, 0.034, and 0.001, respectively). No statistically significant difference was found between chronic migraine patients and healthy controls regarding GCL thickness (average, superior, and inferior) (P value ˃ 0.05).
The average RNFL thickness was significantly thinner in migraine with aura (MwA) than migraine without aura (MwoA) (P = 0.006). The average GCL thickness was thinner in MwA than MwoA (P = 0.039). No statistically significant difference was found between the eyes on the side of the headache and the eyes of the contralateral side regarding RNFL and GCL thickness (P value ˃ 0.05). Age at onset, disease duration, headache frequency, and headache intensity showed an insignificant correlation with OCT parameters.

Conclusion

Retinal changes could be an association with chronic migraine that may be used as a biomarker.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AVR
Average
BCVA
Best-corrected visual acuity
GCL
Ganglion cell layer
INF
Inferior
MwA
Migraine with aura
MwoA
Migraine without aura
NAS
Nasal
NRS
Numeric Rating Scale
NTG
Normal-tension glaucoma
OCT
Optical coherence tomography
r
Correlation coefficients
RNFL
Retinal nerve fiber layer
SD
Stander deviation
SD-OCT
Spectral domain-optical coherence tomography
SPSS
Statistical Package for the Social Science
SUP
Superior
TEMP
Temporal
TGVS
Trigeminovascular system

Introduction

Migraine is a highly prevalent neurological disease that affects about 15% of the general population [1]. It is the sixth highest cause of disability worldwide [2]. It is characterized by moderate to severe recurrent episodes of unilateral, throbbing, or pulsating headache that may be associated with nausea, vomiting, phonophobia, and/or photophobia [3, 4]. Clinically, migraine is divided into two main subtypes: migraine with aura (MwA or classic migraine) and migraine without aura (MwoA or common migraine) [5]. It is estimated that MwA affects 10 to 30% of migraine patients; the aura symptoms appear shortly before or during the development of migraine headaches or no headache may follow [6]. Aura develops over 5 to 20 min and lasts less than an hour. The most common aura symptoms involve the vision, with hallucination/illusion of bright flashing lights and temporary blindness.
Chronic migraine is one of the chronic daily headaches. It is defined as more than fifteen headache days per month over 3 months of which more than eight are migrainous, in the absence of medication overuse, whereas episodic migraine is defined as up to fourteen headache days per month. Chronic migraine affects less than 1% of the population [7]. Its impact can be disabling and the World Health Organization has categorized it as the same disability as dementia and quadriplegia and it is more disabling than blindness and paraplegia [8].
Despite the underlying pathophysiology of migraine is not fully established and many theories have been suggested [9], the neurovascular theory remains one of the most significant mechanisms involved in the pathogenesis of migraine. Neural, vascular, and inflammatory events in migraine headaches are initiated by the activation and sensitization of the trigeminovascular system (TGVS) [10, 11] which consists of the trigeminal nerve fibers that innervate the extracranial and intracranial meningeal blood vessels and ocular structures [12]. The activation of the TGVS inspires the release of vasoactive neurotransmitters from peripheral endings of the trigeminal nerve, resulting in the associated vascular and inflammatory changes that causing pain [10, 13]. Although the temporary cerebral vasospasm that occurs before or during pain leads to a reduction in cerebral blood flow which is limited to the posterior part of one hemisphere, it ends in cerebral hypoperfusion which may involve other areas outside the brain, such as the retina [14]. Despite the arterial vasospasm is a transient phenomenon, the chronic nature of the migraine may lead to permanent structural changes in the brain and retina as permanent ganglion cell damage [14, 15].
Furthermore, migraine is a well-known risk factor for ischemic optic neuropathy and normal-tension glaucoma (NTG) because of the retinal ischemia which arises from retinal artery occlusion [15].
The anatomical structure of the retina is considered to be an extension of the brain. The retinal nerve fiber layer (RNFL) is similar to the gray matter of the brain, and its thickness changes are simply due to axonal damage. From this point of view, the retina is considered to be an easily accessible window into the brain.
Optical coherence tomography (OCT) is a noninvasive imaging procedure that gives high-resolution, cross-sectional images of the RNFL, ganglion cell layer (GCL), and the optic nerve head [16].
Our study aimed to investigate if the RNFL thickness and GCL thickness are affected in patients with chronic migraine to improve the understanding of the etiology and pathophysiology of migraine.

Subjects and methods

This cross-sectional case-control study was conducted on 30 Egyptian patients with chronic migraine [fifteen with aura (MwA), and fifteen without aura (MwoA)]. All the patients met the migraine diagnostic criteria of the headache classification committee of the international headache society, 3rd edition (beta version) [5]. Patients were recruited from headache outpatient clinic of Kasr Al- Ainy Hospitals, Cairo University, from August 2018 to February 2019.
We excluded patients who are smokers, diabetic, hypertensive, dyslipidemic, with chronic renal, hepatic disease, or cardiovascular disease, patients with a history of collagen vascular diseases. Also, patients with a history of central nervous system disorders such as brain tumors, infarction, multiple sclerosis, patients with glaucoma, eye trauma, diabetic neuropathy, dense cataract, corneal opacity, uncorrected refractive error, and history of ocular surgery were excluded.
Thirty healthy controls, with no history of ocular or neurological disease, were recruited from the family members of the patients.
The study was approved by the local ethical committee of the Faculty of Medicine, Cairo University (according to the WMA Declaration of Helsinki), and all the participants gave their informed consent.
The patients were subjected to full neurological history and examination with special emphasis on disease duration, frequency of migraine (attacks per month), duration of migraine headache with and without medications, the severity of the migraine attack (using Numeric Pain Rating Scale) [17], location, character of migraine headache and relation to sleep, associated symptoms, aura symptoms, precipitating and aggravating, and relieving factors.
Full ophthalmological examination of each eye including best-corrected visual acuity (BCVA) testing using Snellen’s charts, visual fields by confrontation, slit lamp examination, intraocular pressure measurement with tonometry, and fundus examination was performed for all participants.
Spectral-domain optical coherence tomography was performed using the Optovue RTVue XR Avanti ™ (Optovu, inc. Fremont, CA, USA) at the laser unit of the Kasr Alainy Hospitals. The optic disk map was used to estimate the average thickness of peripapillary RNFL and the thickness in the superior, inferior, nasal, and temporal quadrants. The macular map protocol was used to measure the GCL thickness, and it was divided into superior and inferior hemispheres. All scans were carried out with ambient lighting and without pupil dilation to ensure patient comfort. Both eyes were examined in all participants and the procedure was completed in about 10 min.

Statistical analysis

Statistical calculations were done using computer programs SPSS (Statistical Package for the Social Science; SPSS Inc., Chicago, IL, USA) version 19 for Microsoft Windows. Data were expressed as mean ± stander deviation (SD) for the parametric variables and as number and percent for the non-parametric variable. A comparison between groups for parametric data was done by independent samples t test (unpaired t test). Chi-square (X2) test was used to compare qualitative variables. Pearson and Spearman correlation coefficients (r) were calculated for the detection of parametric and non-parametric correlations, respectively. The difference was expressed as a probability of value (P value). The difference was considered significant if P < 0.05.

Results

Thirty migraineurs were included in the study; 25 women, 5 men, mean age 30.6 ± 6.7 years, range 18–49 years; mean disease duration 9.23 ± 5.12 years, range 2–20 years; the mean number of attacks per month 9.4 ± 2.465, range 5–14. The duration of the migraine attack without acute medications ranged from 4 to 72 h with a mean of 30.53 ± 18.47.
Fifteen patients had a migraine with aura (50%); 12 patients had visual aura (80%); 2 patients (13%) had mixed auras and visual and sensory auras; and 1 patient had retinal aura (7%).
Regarding migraine headache intensity, the Numeric Rating Scale (NRS) ranged from 5 to 10 with a mean of 7.37 ± 1.089.
Eight patients (26.7%) had their migraine headache attacks on the right side. Seven patients (23.3%) had their migraine headache attacks on the left side while fifteen patients (50%) had their migraine headache attacks on both sides.
RNFL was significantly thinner in patients compared to healthy controls while no significant difference was found between the GCL layer of patients and healthy controls, as shown in Table 1.
Table 1
Comparison of OCT parameters between patients with migraine and healthy controls
OCT parameters
Migraine patients, N = (60 eyes)
Healthy controls, N = (60 eyes)
P value
Mean ± SD
Mean ± SD
AVR-RNFL (um)
103.7 ± 7.157
112.85 ± 5.960
< 0.001*
SUP-RNFL(μm)
125.75 ± 10.088
131.35 ± 19.673
0.022*
INF-RNFL(μm)
129.68 ± 13.363
136.20 ± 19.230
0.045*
NAS-RNFL(μm)
80.27 ± 8.481
90.48 ± 6.008
0.034*
TEMP-RNFL(μm)
77.68 ± 8.584
93.38 ± 7.863
< 0.001*
AVR-GCL(μm)
98.95 ± 5.350
100.52 ± 8.955
0.247
SUP-GCL(μm)
98.65 ± 5.065
98.65 ± 8.346
1.000
INF-GCL(μm)
99.17 ± 5.708
97.28 ± 7.355
0.119
AVR average, GCL ganglion cell layer, INF inferior, NAS nasal, OCT optical coherence tomography, RNFL retinal nerve fiber layer, SUP superior, TEMP temporal
*Significant P value ˂ 0.05
RNFL was significantly thinner in the inferior and nasal quadrants in the patients with MwA than the patients with MwoA, and there was a significant GCL thinning of the superior half in patients with MwA, as shown in Table 2.
Table 2
Comparison of the OCT parameters between patients with MwA and MwoA
OCT parameters
MwA, N = (30 eyes)
MwoA, N = (30 eyes)
P value
Mean ± SD
Mean ± SD
AVR-RNFL (um)
101.23 + 6.468
106.20 + 7.044
0.006*
SUP-RNFL(μm)
123.37 + 9.205
127.77 + 10.598
0.091
INF-RNFL(μm)
125.80 + 13.045
133.57 + 13.302
0.026*
NAS-RNFL(μm)
78.07 + 6.395
82.47 + 9.769
0.043*
TEMP-RNFL(μm)
76.03 + 7.618
79.33 + 9.286
0.138
AVR-GCL(μm)
97.53 + 5.224
100.37 + 5.176
0.039*
SUP-GCL(μm)
96.93 + 4.899
100.37 + 4.701
0.008*
INF-GCL(μm)
98.27 + 5.723
100.07 + 5.644
0.225
AVR average, GCL ganglion cell layer, INF inferior, MwA migraine with aura, MwoA migraine without aura, NAS nasal, OCT optical coherence tomography, RNFL retinal nerve fiber layer, SUP superior, TEMP temporal
*Significant P value ˂ 0.05
RNFL and GCL thickness were not statistically different between the eyes on the side of the headache and the eyes on the contralateral side, as shown in Table 3.
Table 3
Comparison between the OCT parameters in the ipsilateral eyes and the contralateral eyes
OCT parameters
Ipsilateral eye (15 eyes)
Contralateral eye (15 eyes)
P value
Mean ± SD
Mean ± SD
AVR- RNFL (um)
104.27 ± 5.934
105.40± 6.780
0.873
SUP- RNFL(μm)
126.67 ± 8.780
129.20 ± 7.966
0.877
INF- RNFL(μm)
126.93 ± 13.714
130.13 ± 11.825
0.867
NAS-RNFL(μm)
80.60 ± 10.190
81.93 ± 8.075
0.888
TEMP-RNFL(μm)
78.07 ± 11.310
79.87 ± 8.935
0.853
AVR- GCL(μm)
100.46 ± 6.13
99.93 ± 5.70
0.792
SUP- GCL(μm)
100.33 ± 5.67
99.93 ± 5.18
0.759
INF- GCL(μm)
100.33 ± 6.78
99.73 ± 6.07
0.723
AVR average, GCL ganglion cell layer, INF inferior, NAS nasal, OCT optical coherence tomography, RNFL retinal nerve fiber layer, SUP superior, TEMP temporal
No significant correlation was detected between OCT parameters with age, headache duration, headache frequency, and headache intensity, as shown in Table 4.
Table 4
Correlation between OCT parameters with age, disease duration, headache frequency, and headache intensity
Variables
Correlation coefficient
P value
RNFL
Age
− 0.138
0.295
Disease duration
− 0.143
0.276
Frequency
0.161
0.218
Intensity
− 0.019
0.885
GCL
Age
− 0.120
0.361
Disease duration
− 0.219
0.092
Frequency
0.210
0.108
Intensity
− 0.113
0.389
GCL ganglion cell layer, OCT optical coherence tomography, RNFL retinal nerve fiber layer

Discussion

Our study aimed to investigate if the RNFL thickness and GCL thickness are affected in patients with a chronic migraine that may improve the understanding of the etiology and pathophysiology of migraine.
In our study, the average RNFL thickness and the RNFL thickness of all quadrants (superior, inferior, nasal, and temporal) were significantly thinner in the chronic migraine patients, either with or without aura, than the healthy controls. The diminished RNFL thickness means a reduction in the number of axons in migraine patients. Our results come in agreement with different previous studies [1820]. Other studies have demonstrated only RNFL thinning in a specific quadrant; Colak and colleagues [21] reported RNFL thinning in the superior and inferior quadrants, while Martinez and colleagues [22] reported significant decreased RNFL thickness in the temporal quadrant only. Some studies have observed that RNFL thickness was thin in the nasal quadrant only [23, 24] and others have reported RNFL thinning in the superior quadrant [25, 26]. The selective RNFL involvement was attributed to the differences in the vulnerability of the axons to retinal ischemia [27].
On the other hand, Simsek and coworkers [14] reported that no significant difference in the average RNFL thickness or any of the quadrants in migraine patients, with or without aura, and healthy controls except for the nasal quadrant of the right eye, which had a significantly higher value. Also, two previous studies found [16, 28] no statistically significant differences in the retinal thickness between migraine patients and healthy control were found. Finding no significant difference in RNFL may be due to short mean disease duration or low numbers of migraine attacks in those studies [16].
Regarding the GCL thickness, in our study, we found no statistically significant difference between the GCL thickness in migraine patients and healthy control. This goes in agreement with a few earlier reports [21, 29]. However, several studies showed the opposite of what we found [16, 19, 30]; Abdellatif and Fouad [15] reported that the superior and inferior GCL thicknesses were significantly diminished in patients with migraine, either MwA or MwoA, compared to healthy controls. Reggio and colleagues [19] hypothesized that the alteration in the blood supply to the anterior optic nerve head results in an oligemic-hypoxic insult that contributes to ganglion cell damage [19].
We further analyzed the patients with migraine into subgroups: MwA and MwoA; in which we found a significant thinning of the average, inferior, and nasal quadrants of RNFL thickness in patients with MwA than patients with MwoA.
Our study results are in agreement with a study achieved by Ao and coworkers, who reported a significant reduction in the RNFL thickness of the nasal and inferior quadrants in patients with MwA compared to MwoA [24]. Also, the study of Tunç and colleagues showed a significant reduction in the RNFL thickness of the average and superior quadrants between MwA and MwoA [29]. The study of Ekinci and coworkers found non-significant more thinning of the RNFL in patients with MwA than patients with MwoA [30].
During the aura of migraine, the posterior part of the cerebral hemisphere shows cerebral hypoperfusion which can explain the more RNFL thinning in MwA compared to MwoA [22]. However, some studies found no significant difference in the RNFL thickness between patients with MwA and MwoA [14, 19, 31].
Regarding the GCL thickness between the migraine subgroups; MwA and MwoA, our study found that the GCL thickness was thinner in patients with MwA than in patients with MwoA. There was a statistically significant difference in the average and superior half GCL thickness between patients with MwA and patients with MwoA. Our results were in agreement with previous studies [19, 26, 30]. On the other hand, it was found no significant difference in the GCL thickness between patients with MwA and patients with MwoA [20, 21].
As migraine patients experience headaches almost on the one side, we studied the ipsilateral involvement of the RNFL and we found no significant difference in RNFL thickness between the eyes on the side of the headache and the eyes on the contralateral side. Our finding goes in concordant with the study of Gunes and colleagues [27] which had investigated the association between laterality of migraine and RNFL thickness headache side, and they found more thinning of RNFL on the same side of the headache and the asymmetry was not statistically significant [27]. Such thinning of RNFL on the headache side could be attributed to the chronic course of migraine with periodic reduction of the blood flow on the ipsilateral hemisphere during the attacks that could lead to permanent cerebral and retinal damage [32].
In agreement with previous studies, our results showed no significant correlation between the average RNFL or the average GCL thicknesses and the duration of the migraine, the attack frequency, or the severity of the migraine [14, 16, 26, 27].
Theoretically, migraine with long disease duration, higher frequency of attacks, or severe attacks might cause more damage to the RNFL and GCL thickness. In such a manner, Abdellatif and Fouad found that the duration of migraine was negatively correlated with superior and inferior RNFL and GCL, while the severity of migraine showed a significant negative correlation with inferior and temporal RNFL and the superior and inferior GCL [20]. Also, Martinez and colleagues reported a similar negative correlation between the severity and duration of migraine and RNFL thickness [22].
The disparity between the results of the current study and previous studies may be attributed to differences in methodology and sample size, mean age of the population, ethnic variations, and the absence of standardized migraine characteristics, including length of migraine history, severity, and frequency of attacks.

Conclusion

Migraine with both types (MwA and MwoA) could reduce the RNFL and GCL thicknesses. The axonal loss requires oversight on testing the RNFL thickness in migraine patients. Further researches may deduct the importance of OCT findings as an investigative surrogate for migraine.

Acknowledgements

Not applicable.
All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Our study was approved by the ethical committee of the Department of Neurology, Faculty of Medicine, Cairo University, in June 2016, but Cairo University does not provide an approval reference number.
An informed written consent was taken from each participant involved in this study prior to the conduct of any study-related activities.
All data obtained from participants were confidential and were not used outside the study. The patients had the rights to withdraw from the study at any time without giving any reason.
Not applicable

Competing interests

None of the authors has any conflict of interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21.PubMedCrossRef Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21.PubMedCrossRef
3.
Zurück zum Zitat Ascaso FJ, Marco S, Mateo J, Martínez M, Esteban O, Grzybowski A. Optical coherence tomography in patients with chronic migraine: literature review and update. Front Neurol. 2017;8:684.PubMedPubMedCentralCrossRef Ascaso FJ, Marco S, Mateo J, Martínez M, Esteban O, Grzybowski A. Optical coherence tomography in patients with chronic migraine: literature review and update. Front Neurol. 2017;8:684.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Global burden of disease study collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800.CrossRef Global burden of disease study collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800.CrossRef
5.
Zurück zum Zitat Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.CrossRef Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.CrossRef
6.
Zurück zum Zitat Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci. 2012;35(8):507–20.PubMedCrossRef Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci. 2012;35(8):507–20.PubMedCrossRef
7.
Zurück zum Zitat Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–6.PubMedCrossRef Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–6.PubMedCrossRef
8.
Zurück zum Zitat Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422–35.PubMedPubMedCentralCrossRef Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422–35.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–95.PubMedCrossRef Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–95.PubMedCrossRef
10.
Zurück zum Zitat Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24(Suppl. 2):2–7.PubMedCrossRef Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24(Suppl. 2):2–7.PubMedCrossRef
11.
Zurück zum Zitat Ayata C. Cortical spreading depression triggers migraine attack: pro. Headache. 2010;50(4):725–30.PubMedCrossRef Ayata C. Cortical spreading depression triggers migraine attack: pro. Headache. 2010;50(4):725–30.PubMedCrossRef
12.
Zurück zum Zitat Aguggia M, Saracco MG, Cavallini M, Bussone G, Cortelli P. Sensitization and pain. Neurol Sci. 2013;34:S37–40.PubMedCrossRef Aguggia M, Saracco MG, Cavallini M, Bussone G, Cortelli P. Sensitization and pain. Neurol Sci. 2013;34:S37–40.PubMedCrossRef
14.
Zurück zum Zitat Simsek IB, Aygun D, Yildiz S. Retinal nerve fiber layer thickness in migraine patients with or without aura. Neuroophthalmology. 2015;39(1):17–21.PubMedCrossRef Simsek IB, Aygun D, Yildiz S. Retinal nerve fiber layer thickness in migraine patients with or without aura. Neuroophthalmology. 2015;39(1):17–21.PubMedCrossRef
15.
Zurück zum Zitat Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20(3):319–49.PubMedCrossRef Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20(3):319–49.PubMedCrossRef
16.
Zurück zum Zitat Gunes A, Karadag AS, Yazgan S, Celik HU, Simsek A. Evaluation of retinal nerve fiber layer, ganglion cell layer and choroidal thickness with optical coherence tomography in migraine patients: a case-control study. Clin Exp Optom. 2018;101(1):109–15.PubMedCrossRef Gunes A, Karadag AS, Yazgan S, Celik HU, Simsek A. Evaluation of retinal nerve fiber layer, ganglion cell layer and choroidal thickness with optical coherence tomography in migraine patients: a case-control study. Clin Exp Optom. 2018;101(1):109–15.PubMedCrossRef
17.
Zurück zum Zitat Jensen MP, Karoly P, O’Riordan EF, Bland F, Burns RS. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989;5:153–9.PubMedCrossRef Jensen MP, Karoly P, O’Riordan EF, Bland F, Burns RS. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989;5:153–9.PubMedCrossRef
18.
Zurück zum Zitat Feng YF, Guo H, Huang JH, Yu JG, Yuan F. Retinal nerve fiber layer thickness changes in migraine: a meta-analysis of case-control studies. Curr Eye Res. 2016;41(6):814–22.PubMedCrossRef Feng YF, Guo H, Huang JH, Yu JG, Yuan F. Retinal nerve fiber layer thickness changes in migraine: a meta-analysis of case-control studies. Curr Eye Res. 2016;41(6):814–22.PubMedCrossRef
19.
Zurück zum Zitat Reggio E, Chisari CG, Ferrigno G, Patti F, Donzuso G, Sciacca G, et al. Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography. J Neurol. 2017;264(3):494–502.PubMedCrossRef Reggio E, Chisari CG, Ferrigno G, Patti F, Donzuso G, Sciacca G, et al. Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography. J Neurol. 2017;264(3):494–502.PubMedCrossRef
20.
Zurück zum Zitat Abdellatif MK, Fouad MM. Effect of duration and severity of migraine on retinal nerve fiber layer, ganglion cell layer, and choroidal thickness. Eur J Ophthalmol. 2018;28(6):714–21.PubMedCrossRef Abdellatif MK, Fouad MM. Effect of duration and severity of migraine on retinal nerve fiber layer, ganglion cell layer, and choroidal thickness. Eur J Ophthalmol. 2018;28(6):714–21.PubMedCrossRef
21.
Zurück zum Zitat Colak HN, Kantarcı FA, Tatar MG, Eryilmaz M, Uslu H, Goker H, et al. Retinal nerve fiber layer, ganglion cell complex, and choroidal thicknesses in migraine. Arq Bras Oftalmol. 2016;79(2):78–81.PubMedCrossRef Colak HN, Kantarcı FA, Tatar MG, Eryilmaz M, Uslu H, Goker H, et al. Retinal nerve fiber layer, ganglion cell complex, and choroidal thicknesses in migraine. Arq Bras Oftalmol. 2016;79(2):78–81.PubMedCrossRef
22.
Zurück zum Zitat Martinez A, Proupim N, Sanchez M. Retinal nerve fiber layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol. 2008;92(8):1069–75.PubMedCrossRef Martinez A, Proupim N, Sanchez M. Retinal nerve fiber layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol. 2008;92(8):1069–75.PubMedCrossRef
23.
Zurück zum Zitat Sorkhabi R, Mostafaei S, Ahoor M, Talebi M. Evaluation of retinal nerve fiber layer thickness in migraine. Iran J of neurol. 2013;12(2):51. Sorkhabi R, Mostafaei S, Ahoor M, Talebi M. Evaluation of retinal nerve fiber layer thickness in migraine. Iran J of neurol. 2013;12(2):51.
24.
Zurück zum Zitat Ao R, Wang R, Yang M, Wei S, Shi X, Yu S. Altered retinal nerve fiber layer thickness and choroid thickness in patients with migraine. Eur Neurol. 2018;80(3-4):130–7.PubMedCrossRef Ao R, Wang R, Yang M, Wei S, Shi X, Yu S. Altered retinal nerve fiber layer thickness and choroid thickness in patients with migraine. Eur Neurol. 2018;80(3-4):130–7.PubMedCrossRef
25.
Zurück zum Zitat Kirbas S, Tufekci A, Turkyilmaz K, Kirbas A, Oner V, Durmus M. Evaluation of the retinal changes in patients with chronic migraine. Acta Neurol Belg. 2013;113(2):167–72.PubMedCrossRef Kirbas S, Tufekci A, Turkyilmaz K, Kirbas A, Oner V, Durmus M. Evaluation of the retinal changes in patients with chronic migraine. Acta Neurol Belg. 2013;113(2):167–72.PubMedCrossRef
26.
Zurück zum Zitat Gipponi S, Scaroni N, Venturelli E, Forbice E, Rao R, Liberini P, et al. Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci. 2013;34(6):841–5.PubMedCrossRef Gipponi S, Scaroni N, Venturelli E, Forbice E, Rao R, Liberini P, et al. Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci. 2013;34(6):841–5.PubMedCrossRef
27.
Zurück zum Zitat Gunes A, Demirci S, Tok L, Tok O, Demirci S, Kutluhan S. Is retinal nerve fiber layer thickness change related to headache lateralization in migraine? Korean J Ophthalmol. 2016;30(2):134–9.PubMedPubMedCentralCrossRef Gunes A, Demirci S, Tok L, Tok O, Demirci S, Kutluhan S. Is retinal nerve fiber layer thickness change related to headache lateralization in migraine? Korean J Ophthalmol. 2016;30(2):134–9.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Yülek F, Dirik EB, Eren Y, Simavl H, Uğurlu N, Çağıl N, et al. Macula and retinal nerve fiber layer in migraine patients: analysis by spectral-domain optic coherence tomography. Semin Ophthalmol. 2015;30(2):124–8.PubMedCrossRef Yülek F, Dirik EB, Eren Y, Simavl H, Uğurlu N, Çağıl N, et al. Macula and retinal nerve fiber layer in migraine patients: analysis by spectral-domain optic coherence tomography. Semin Ophthalmol. 2015;30(2):124–8.PubMedCrossRef
29.
Zurück zum Zitat Tunç A, Güngen BD, Evliyaoğlu F, Aras YG, Tekeşin AK. Evaluation of retinal nerve fiber layer, ganglion cell layer and macular changes in patients with migraine. Acta Neurol Belg. 2017;117(1):121–9.PubMedCrossRef Tunç A, Güngen BD, Evliyaoğlu F, Aras YG, Tekeşin AK. Evaluation of retinal nerve fiber layer, ganglion cell layer and macular changes in patients with migraine. Acta Neurol Belg. 2017;117(1):121–9.PubMedCrossRef
30.
Zurück zum Zitat Ekinci M, Ceylan E, Çağatay HH, Keleş S, Hüseyinoğlu N, Tanyıldız B, et al. Retinal nerve fibre layer, ganglion cell layer and choroid thinning in migraine with aura. BMC Ophthalmol. 2014;14(1):75.PubMedPubMedCentralCrossRef Ekinci M, Ceylan E, Çağatay HH, Keleş S, Hüseyinoğlu N, Tanyıldız B, et al. Retinal nerve fibre layer, ganglion cell layer and choroid thinning in migraine with aura. BMC Ophthalmol. 2014;14(1):75.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Demircan S, Ataş M, Yüksel SA, Ulusoy MD, Yuvacı İ, Arifoğlu HB, et al. The impact of migraine on posterior ocular structures. J Ophthalmol. 2015;2015:868967.PubMedPubMedCentralCrossRef Demircan S, Ataş M, Yüksel SA, Ulusoy MD, Yuvacı İ, Arifoğlu HB, et al. The impact of migraine on posterior ocular structures. J Ophthalmol. 2015;2015:868967.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Simsek IB. Retinal nerve fiber layer thickness of migraine patients with or without white matter lesions. Neuroophthalmology. 2017;41:7–11.PubMedCrossRef Simsek IB. Retinal nerve fiber layer thickness of migraine patients with or without white matter lesions. Neuroophthalmology. 2017;41:7–11.PubMedCrossRef
Metadaten
Titel
Retinal nerve fiber layer and ganglion cell layer changes using optical coherence tomography in patients with chronic migraine: a case-control study
verfasst von
Dalia M. Labib
Montaser Hegazy
Soheir Mohamed Esmat
Enas Abdel Hamid Ali
Foraysa Talaat
Publikationsdatum
01.12.2020
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-020-00218-8

Weitere Artikel der Ausgabe 1/2020

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.